K Health, a NYC- and Tel Aviv, Israel-based AI powered telemedicine company, closed a $48m series C funding.
The round was led by 14W and Mangrove Capital with participation from Anthem, Lerer Hippeau and Primary Venture Partners.
The company intends to use the funds to grow its telemedicine offering and translate the platform in Spanish.
Led by co-founder Allon Bloch, K Health provides an app that allows patients to check their symptoms and chat with a doctor. The company’s platform ingests medical histories, clinical outcomes, and the collective experience of more than 10,000 doctors to deliver treatment information on hundreds of diseases. The app asks questions about symptoms and accounts for age, gender, and medical history as it investigates health of a user. Quickly, the user will see how people in the same demographic group were diagnosed and treated by doctors when they were in the same situation. Users can chat with the doctor on call throughout a health episode for a diagnosis, advice, prescriptions and lab test orders. K Health complies with both HIPAA + GDPR, the world’s leading standards for information security and privacy. It uses anonymized data to make the app smarter, but it will never sell, rent, or share personal health information.